Volunteer for NIAID-funded clinical studies related to vaginitis on ClinicalTrials.gov.
To control vaginitis, research is under way to determine the factors that promote the growth and disease-causing potential of vaginal microbes. This information could help improve efforts to treat and prevent vaginitis. No longer considered merely a harmless annoyance, vaginitis is the object of serious studies as scientists try to clarify its role in such conditions as pelvic inflammatory disease and pregnancy-related complications.
This research has uncovered important information about yeast’s reproductive behavior, which could lead the way to new treatments for yeast infections.
Researchers discovered an association between having lactobacilli as normal microflora in the vagina and protection from bacterial vaginosis (BV). They are working on developing a lactobacillus vaginal suppository that helps these beneficial bacteria grow in the vagina. Researchers are now studying the use of vaginal lactobacilli suppositories with oral metronidazole to treat and prevent BV.
Other NIAID-funded researchers completed sequencing the genetic code of Trichomonas vaginalis. Scientists are beginning to understand its biology and to find new and innovative ways to prevent the disease it causes. T. vaginalis is also of particular interest to medical researchers because of its role in HIV transmission, infant morbidity, and the predisposition to cervical cancer.
back to top
Last Updated March 19, 2009